IRIS
CONFORTI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 384
NA - Nord America 247
EU - Europa 96
SA - Sud America 81
AF - Africa 20
Totale 828
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 213
SG - Singapore 143
CN - Cina 94
BR - Brasile 59
VN - Vietnam 52
IT - Italia 24
FR - Francia 19
IN - India 19
CA - Canada 16
HK - Hong Kong 13
MX - Messico 10
BD - Bangladesh 9
PH - Filippine 9
AR - Argentina 8
ID - Indonesia 8
IQ - Iraq 7
FI - Finlandia 6
GB - Regno Unito 6
MA - Marocco 6
RU - Federazione Russa 6
DE - Germania 5
EG - Egitto 5
ES - Italia 5
SA - Arabia Saudita 5
IE - Irlanda 4
EC - Ecuador 3
JP - Giappone 3
KH - Cambogia 3
MY - Malesia 3
NG - Nigeria 3
PE - Perù 3
PK - Pakistan 3
QA - Qatar 3
TR - Turchia 3
AL - Albania 2
AT - Austria 2
BY - Bielorussia 2
CH - Svizzera 2
CL - Cile 2
GT - Guatemala 2
JM - Giamaica 2
NI - Nicaragua 2
NL - Olanda 2
RS - Serbia 2
UA - Ucraina 2
UY - Uruguay 2
AO - Angola 1
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
GM - Gambi 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
PY - Paraguay 1
RO - Romania 1
SI - Slovenia 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 828
Salva come PNG Salva come JPEG
Città #
Singapore 41
Ho Chi Minh City 21
Santa Clara 21
Beijing 20
Ashburn 19
New York 19
Buffalo 15
Hong Kong 13
Hanoi 12
Los Angeles 12
Dallas 8
São Paulo 8
Chandler 7
San Jose 7
Shanghai 7
Helsinki 6
Milan 6
Paris 6
The Dalles 6
Wilmington 6
Baghdad 5
Charlotte 5
Hillsboro 5
Casablanca 4
Nanjing 4
Naples 4
Benin City 3
Cairo 3
Da Nang 3
Doha 3
Dublin 3
Las Vegas 3
Lawrence 3
Phnom Penh 3
Princeton 3
Rio de Janeiro 3
Rome 3
Toronto 3
Acapulco de Juárez 2
Assago 2
Atlanta 2
Belgrade 2
Brooklyn 2
Dammam 2
Guatemala City 2
Jeddah 2
Kolkata 2
Lima 2
Managua 2
Manila 2
Maringá 2
Mexico City 2
Montevideo 2
Montreal 2
Mérida 2
Pasadena 2
Philadelphia 2
Piscataway 2
Quito 2
San Mateo 2
Santiago 2
Winchester 2
Woodbridge 2
Abbottabad 1
Aberdeen 1
Acreúna 1
Adamantina 1
Adliswil 1
Agadir 1
Agra 1
Amman 1
Amparo 1
Amsterdam 1
Anand 1
Ancol 1
Angeles City 1
Ann Arbor 1
Arecibo 1
Assis 1
Athens 1
Bandeira do Sul 1
Barquisimeto 1
Barranda 1
Basildon 1
Basra 1
Bauru 1
Bebedouro 1
Belo Horizonte 1
Berrechid 1
Blagoevgrad 1
Blainville 1
Bologna 1
Boqueirão do Leão 1
Boulder 1
Bowie 1
Brasília 1
Bremen 1
Brikama 1
Burzaco 1
Bình Dương 1
Totale 410
Salva come PNG Salva come JPEG
Nome #
The Rare Entity of Basaloid Thymic Carcinoma: A Multicentric Retrospective Analysis from the Italian Collaborative Group for ThYmic MalignanciEs (TYME) 93
Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapy 82
Resound Trial: A phase 2 study of regorafenib in patients with thymoma (type B2-B3) and thymic carcinoma previously treated with chemotherapy 55
SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis 43
Avelumab combined with axitinib for patients with advanced thymoma B3 and thymic carcinoma 39
Muscle and Muscle-like Autoantigen Expression in Myasthenia Gravis Thymus: Possible Molecular Hint for Autosensitization 36
Bridging Knowledge Gaps in Small Cell Lung Cancer: Data, Challenges and Priorities 31
Correlation between treatments and outcomes of patients with EGFR-mutated non-small-cell lung cancer that transitioned into small-cell lung cancer: an international retrospective study 29
Aprepitant use during chemotherapy and association with survival in women with early breast cancer 13
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion 12
“Heterogeneity of treatment effect on patients’ long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer.” 12
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy 12
Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis 11
Comparison of filgrastim and pegfilgrastim prophylaxis in sarcoma patients receiving highly myelosuppressive chemotherapy 10
Sex and cancer immunotherapy: Current understanding and challenges 9
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis 9
Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19 9
Dasatinib sensitises KRAS-mutant cancer cells to mitogen-activated protein kinase kinase inhibitor via inhibition of TAZ activity 9
Sex-based differences of the tumor mutational burden and T-cell inflammation of the tumor microenvironment 9
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations 8
Boosting anticancer immunotherapy through androgen receptor blockade 8
Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy 8
Ethnicity-based differences in breast cancer features and responsiveness to CDK4/6 inhibitors combined with endocrine therapy 8
Surrogacy of Pathologic Complete Response in Trials of Neoadjuvant Therapy for Early Breast Cancer Critical Analysis of Strengths, Weaknesses, and Misinterpretations 8
Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center 8
Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with outcome of patients treated with BRAF inhibitors 8
EGFR tyrosine kinase inhibitors beyond focal progression obtain a prolonged disease control in patients with advanced adenocarcinoma of the lung 8
Under-representation of women in Randomized Clinical Trials testing anticancer immunotherapy may undermine female patients care. A call to action 8
High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network study 7
Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy 7
Molecular and clinical features of second-generation anaplastic lymphoma kinase inhibitors ceritinib 7
Antitumor activity of sorafenib and imatinib in a patient with thymic carcinoma harboring c-KIT exon 13 missense mutation K642E 7
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 7
Estrogen Signaling in Early-Stage Breast Cancer: Impact on Neoadjuvant Chemotherapy and Immunotherapy 7
Extensive vitiligo associated to response to c-kit inhibitor in metastatic mucosal melanoma 7
Primary ipilimumab/nivolumab followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome 7
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials 7
A phase II study of regorafenib in patients with thymic epithelial tumours previously treated with chemotherapy 7
Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AML 7
Immunomodulatory drugs in multiple myeloma: from molecular mechanisms of action to clinical practice 7
Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study 7
Xpo1 Inhibition: A Promising Therapeutic Strategy in Thymic Epithelial Tumors 6
Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome 6
The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high‐volume referral centers 6
Metaplastic breast cancers and triple-negative breast cancers of no special type: are they prognostically different? A systematic review and meta-analysis 6
Thymic epithelial tumors: From biology to treatment 6
Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator? 6
Sex as a predictor of response to cancer immunotherapy Reply 6
Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta-analysis of randomized clinical trials 6
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence 6
Different Response to Immunotherapy According to Melanoma Histologic Subtype 6
Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma 6
Association of Anticancer Immune Checkpoint Inhibitors With Patient-Reported Outcomes Assessed in Randomized Clinical Trials A Systematic Review and Meta-analysis 6
Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis 6
Editorial: Differential Efficacy of Immune Checkpoint Inhibitors due to Age and Sex Factors 6
Sex-based differences of the intratumoral immune-infiltrate 6
Investigational drugs for the treatment of thymic cancer: a focus on phase 1 and 2 clinical trials 6
Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trial 6
The effect of patient sex on the efficacy and safety of anticancer immunotherapy 6
EGFR-TKI Plus Anti-Angiogenic Drugs in EGFR-Mutated Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Clinical Trials 6
Immune-checkpoint inhibitors in anal squamous cell carcinoma: a systematic review and meta-analysis 6
Targeting ALK in patients with advanced Non Small Cell Lung Cancer: Biology, diagnostic and therapeutic options 6
Metaplastic breast cancer: Prognostic and therapeutic considerations 5
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis 5
Sex-based dimorphism in the SARS-CoV2 virulence 5
EPIDERMAL GROWTH FACTORS TYROSINE-KINASE INHIBITORS (EGFR-TKI) EFFICACY IN NSCLC PATIENTS WITH HIGH POLYSOMY OF CHROMOSOME 7 AND EGFR/KRAS WILD TYPE TUMORS 5
Therapeutic Effects of XPO1 Inhibition in Thymic Epithelial Tumors 5
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis 5
Original Research Thymic carcinoma with Lynch syndrome or microsatellite instability, a rare entity responsive to immunotherapy 5
Sex Differences in Efficacy and Toxicity of Systemic Cancer Treatments: Role of the Microbiome 5
Molecular Pathways: Anticancer Activity by Inhibition of Nucleocytoplasmic Shuttling 5
Course of Sars-CoV2 Infection in Patients with Cancer Treated with anti-PD-1: A Case Presentation and Review of the Literature 5
Exemestane Plus Ovarian Function Suppression Is the Best Adjuvant Treatment of Premenopausal Women With Endocrine-Responsive Breast Cancer at Higher Risk of Relapse and With HER2-Negative Tumors 5
Genetic Alterations of Melanoma Brain Metastases: A Systematic Review and Meta-Analysis 5
Successful treatment with avapritinib in patient with mucosal metastatic melanoma 5
Gender-Based Differences in the Efficacy of Anti-EGFR/BRAF/MEK Targeted Therapy in Patients with BRAF-Mutated Metastatic Colorectal Cancer 4
PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors 4
Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review 4
Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review 4
Biological and clinical features of early triple-negative invasive lobular carcinomas of the breast 4
Metaplastic breast cancers and triple-negative breast cancers of no special type: are they prognostically different? A systematic review and meta-analysis 3
Erlotinib Efficacy in NSCLC Patients with High Polysomy of Chromosome 7 and EGFR/KRas Wild-Type Tumors 3
Molecular features and clinical outcome of lung malignancies in very young people 3
Pathological and clinical features of enteric adenocarcinoma of the thymus. A pooled analysis of cases from a reference center and systematic review of the literature 3
Sex hormones, the anticancer immune response, and therapeutic opportunities 3
Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer 2
Extended Endocrine Therapy and Survival for Breast Cancer Subtypes in Premenopausal Patients 2
Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials 1
Totale 917
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.835
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.835
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202218 0 1 0 2 0 0 0 4 2 2 7 0
2022/202325 6 0 3 3 1 3 0 1 3 3 2 0
2023/202422 0 3 2 0 0 6 1 2 0 1 3 4
2024/202551 0 0 0 0 0 5 6 3 1 9 11 16
2025/2026782 17 4 10 27 8 12 42 306 128 78 56 94
Totale 917